RESEARCH - Guarded optimism for experimental MS drug

[Guest guest]

Guarded Optimism for Experimental MS Drug

Alemtuzumab Appears to Repair Damage to Brain in Patients With MS

By Salynn Boyles

WebMD Health News

Reviewed by Louise Chang, MD

Oct. 22, 2008 -- An experimental multiple sclerosis drug proved to be

much more effective for the treatment of early MS than a widely used

treatment in a study, but the efficacy came at a price.

Patients with early relapsing-remitting MS treated with the drug

alemtuzumab had far fewer relapses and evidence of MS progression than

patients treated with the approved treatment, interferon beta-1a.

Remarkably, some patients who got the experimental drug had less

disability associated with their disease three years after starting

the study than at entry, raising hopes that the treatment might stop

the disease in its tracks before it progresses to its crippling stage.

****************************************************

Read the rest of the article here:

http://www.webmd.com/multiple-sclerosis/news/20081022/guarded-optimism-for-exper\

imental-ms-drug

Not an MD

[Guest guest]

WOW, - this is exciting news!! My oldest daughter was diagnosed

about 9 years ago with MS - she will be 20 tomorrow. This could be an

answer to prayer for her.............Doreen

>

> Guarded Optimism for Experimental MS Drug

> Alemtuzumab Appears to Repair Damage to Brain in Patients With MS

>

>

> By Salynn Boyles

> WebMD Health News

> Reviewed by Louise Chang, MD

>

>

> Oct. 22, 2008 -- An experimental multiple sclerosis drug proved to

> be much more effective for the treatment of early MS than a widely

> used treatment in a study, but the efficacy came at a price.

>

> Patients with early relapsing-remitting MS treated with the drug

> alemtuzumab had far fewer relapses and evidence of MS progression

> than patients treated with the approved treatment, interferon

> beta-1a.

>

> Remarkably, some patients who got the experimental drug had less

> disability associated with their disease three years after starting

> the study than at entry, raising hopes that the treatment might stop

> the disease in its tracks before it progresses to its crippling

> stage.

>

>

> ****************************************************

> Read the rest of the article here:

>

>

http://www.webmd.com/multiple-sclerosis/news/20081022/guarded-optimism-for-exper\

imental-ms-drug

>

>

>

> Not an MD

>

[Guest guest]

I really hope so, Doreen!

Not an MD

On Thu, Oct 23, 2008 at 12:18 PM, Mimi <mimi212@...> wrote:

> WOW, - this is exciting news!! My oldest daughter was diagnosed

> about 9 years ago with MS - she will be 20 tomorrow. This could be an

> answer to prayer for her.............Doreen

[Guest guest]

Man, I hate it when I get things backwards and all goofy. My daughter

WAS diagnosed 9 years ago, but she will be 30 tomorrow - not 20.

Doreen

> >

> > Guarded Optimism for Experimental MS Drug

> > Alemtuzumab Appears to Repair Damage to Brain in Patients With MS

> >